trending Market Intelligence /marketintelligence/en/news-insights/trending/9ep_wklibgofynexxrxrpa2 content esgSubNav
In This List

Inspyr Therapeutics' chief medical officer, directors resign

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Inspyr Therapeutics' chief medical officer, directors resign

Inspyr Therapeutics, Inc. said chief medical officer Ronald Shazer resigned from his position, effective Feb. 12.

Directors Peter Grebow and Richard Buller resigned from the company's board, effective Feb. 9.

The board resignations did not result from any disagreement with the company or matter relating to its operations, policies or practices, the Westlake Village, Calif.-based drug developer said in a Feb. 14 filing with the SEC.